Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120Nina D. Russell, Lawrence Corey, Barney S. Graham et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006Cited by 104
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteersPaul Goepfert, Thomas G. Evans, Georgia D. Tomaras et al.|Vaccine|2006Cited by 93
Campylobacter jejuni transcriptional and genetic adaptation during human infectionAlexander A. Crofts, M. Stephen Trent, David A. Sack et al.|Nature Microbiology|2018Cited by 85